Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6200771A · kind A · utility
5Cited by
53References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1998 |
| Grant date | Mar 13, 2001 |
| Priority date | — |
| Expiry date | Oct 15, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for identifying compounds useful for the treatment of neoplasia involves acertaining whether such compounds exhibit an ability to inhibit a PDE that is characterized by cGMP specificity, cooperative kinetic behavior and insensitivity to phosphorylation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.